Amanta Healthcare
AMANTANSE

Amanta Healthcare

₹185.10-2.11 (1.13%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
183.47
Today’s high
185.10
52 week low
92.00
52 week high
205.57
Open price
183.47
Previous close
187.21
Live volume
96,563
Lower circuit
181.40
Upper circuit
188.80

Fundamentals

Market Cap
₹727Cr
ROE
7.46%
P/E Ratio(TTM)
49.52
EPS(TTM)
3.78
P/B Ratio
3.30
Dividend Yield
0.00%
Industry P/E
50.91
Book Value
56.71
Debt to Equity
1.11
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹69.44
-11.71%
Profit (Cr)
₹3.31
-40.14%
020406080
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+5%
3Y CAGR+3%
Profit growthValue
1Y (TTM)-6%
3Y CAGR+108%

About

Amanta Healthcare Limited manufactures sterile liquid parenterals, employing Blow-Fill-Seal (BFS) technology for various therapeutic categories.;
CEO/MD
Bhavesh Patel
Founded in
1994
NSE symbol
AMANTA

Shareholding pattern

Aug '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Mutual Funds Invested (1)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,703.80
-36.60 (0.77%)
L
    H
    21,702.5029.525.16
    ₹2,517.20
    -23.50 (0.92%)
    L
      H
      19,323.3128.55.39
      ₹7,106.50
      -29.50 (0.41%)
      L
        H
        17,802.75104.9520.4
        Natco PharmaNATCOPHARM
        ₹853.80
        -3.80 (0.44%)
        L
          H
          15,371.2113.431.67
          Livesquawk
          Amanta Healthcare's Q1 EBITDA fell to ₹145M from ₹149M YoY. Q1 EBITDA margin declined to 21.1% from 22.8% YoY.
          Livesquawk
          Amanta Healthcare schedules analyst and investor meeting on July 9 at 5 PM.
          Livesquawk
          Amanta Healthcare's co-promoter acquired 63 lakh shares on June 17. The purchase represents a 16.3% stake through the open market.
          2026
          5
          Aug
          Quarterly Result
          Release date
          19
          May
          Annual Result
          Release date
          10
          Feb
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          26
          Sep
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks